MCRB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Seres Therapeutics (MCRB) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MCRB is expected to report earnings to fall 40.39% to -19 cents per share on March 11

Seres Therapeutics MCRB Stock Earnings Reports

Q4'24

Est.

$-0.20

Q3'24

Missed

by $0.25

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.07

Q4'23

Beat

by $0.19

The last earnings report on November 13 showed earnings per share of -33 cents, missing the estimate of -7 cents. With 2.79M shares outstanding, the current market capitalization sits at 157.39M.

View a ticker or compare two or three

Compare

MCRB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MCRB
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of novel treatments for diseases related to the human microbiome

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

101 Cambridgepark Drive

Phone

+1 617 945-9626

Employees

233

Web

https://www.serestherapeutics.com